- Home
- Publications
- Publication Search
- Publication Details
Title
5-ALA and FDA approval for glioma surgery
Authors
Keywords
5-ALA, FDA, Optical imaging, Glioblastoma, High-grade gliomas, Intraoperative imaging, Brain tumors, Gliomas
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-14
DOI
10.1007/s11060-019-03098-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma
- (2018) Martin J. B. Taphoorn et al. JAMA Oncology
- Fluorescence-guided surgery for high-grade gliomas
- (2018) Nikita Lakomkin et al. JOURNAL OF SURGICAL ONCOLOGY
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Adult Glioblastoma
- (2017) Brian M. Alexander et al. JOURNAL OF CLINICAL ONCOLOGY
- The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
- (2016) Yan Michael Li et al. JOURNAL OF NEUROSURGERY
- A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas
- (2016) Darryl Lau et al. JOURNAL OF NEUROSURGERY
- Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients
- (2016) James S. Cordova et al. NEURO-ONCOLOGY
- Association of the Extent of Resection With Survival in Glioblastoma
- (2016) Timothy J. Brown et al. JAMA Oncology
- Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
- (2015) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided Surgery
- (2015) J. Scott Cordova et al. MOLECULAR IMAGING AND BIOLOGY
- What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?
- (2015) Costas G. Hadjipanayis et al. NEUROSURGERY
- Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA–enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment
- (2014) Jan Coburger et al. Neurosurgical Focus
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quantitative Tumor Segmentation for Evaluation of Extent of Glioblastoma Resection to Facilitate Multisite Clinical Trials
- (2014) James S. Cordova et al. Translational Oncology
- Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma
- (2013) Terri S. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
- (2013) Mark R. Gilbert et al. JOURNAL OF CLINICAL ONCOLOGY
- Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials
- (2013) K. Han et al. NEURO-ONCOLOGY
- 5-Aminolevulinic Acid-derived Tumor Fluorescence
- (2013) Walter Stummer et al. NEUROSURGERY
- Intraoperative Fluorescence-Guided Resection of High-Grade Malignant Gliomas Using 5-Aminolevulinic Acid–Induced Porphyrins: A Systematic Review and Meta-Analysis of Prospective Studies
- (2013) Shiguang Zhao et al. PLoS One
- NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
- (2012) Roger Stupp et al. EUROPEAN JOURNAL OF CANCER
- Refining endpoints in brain tumor clinical trials
- (2012) Christina A. Meyers et al. JOURNAL OF NEURO-ONCOLOGY
- Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery
- (2012) Walter Stummer et al. JOURNAL OF NEURO-ONCOLOGY
- Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival
- (2012) Daniel Orringer et al. JOURNAL OF NEUROSURGERY
- Measuring Clinical Benefit: Use of Patient-Reported Outcomes (PRO) in Primary Brain Tumor Clinical Trials
- (2012) Terri S. Armstrong Current Oncology Reports
- Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30
- (2012) Leonard Chiu et al. Expert Review of Pharmacoeconomics & Outcomes Research
- An extent of resection threshold for newly diagnosed glioblastomas
- (2011) Nader Sanai et al. JOURNAL OF NEUROSURGERY
- Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance
- (2011) D. Kuhnt et al. NEURO-ONCOLOGY
- Pathological characterization of the glioblastoma border as shown during surgery using 5-aminolevulinic acid-induced fluorescence
- (2011) Miguel Angel Idoate et al. NEUROPATHOLOGY
- Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience
- (2010) Ricardo Díez Valle et al. JOURNAL OF NEURO-ONCOLOGY
- Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study
- (2010) Walter Stummer et al. JOURNAL OF NEUROSURGERY
- Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid–induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters
- (2010) David W. Roberts et al. JOURNAL OF NEUROSURGERY
- FIVE-AMINOLEVULINIC ACID FOR FLUORESCENCE-GUIDED RESECTION OF RECURRENT MALIGNANT GLIOMAS
- (2009) Arya Nabavi et al. NEUROSURGERY
- FDA Drug Approval Summary: Bevacizumab (Avastin(R)) as Treatment of Recurrent Glioblastoma Multiforme
- (2009) M. H. Cohen et al. ONCOLOGIST
- Estimation of Brain Deformation for Volumetric Image Updating in Protoporphyrin IX Fluorescence-Guided Resection
- (2009) Pablo A. Valdés et al. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY
- Treatment with bevacizumab and irinotecan for recurrent high-grade glial tumors
- (2008) Felix Bokstein et al. CANCER
- Independent association of extent of resection with survival in patients with malignant brain astrocytoma
- (2008) Matthew J. McGirt et al. JOURNAL OF NEUROSURGERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More